Spyre Therapeutics, Inc. (SYRE)

34.66 +0.98 (+2.91%) USD  |  NASDAQ  |  Dec 10, 16:00
35.13 +0.47 (+1.36%) After-Hours: 04:25
More

Spyre Therapeutics Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
PTC Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Oragenics, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade